Product
Influenza ModRNA Vaccine
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINES AGAINST INFLUENZA IN HEALTHY ADULTSStatus: Recruiting, Estimated PCD: 2025-02-05